Thierry C.
- Country
- Belgium
- Department
- Internal Medicine/Oncology/Hematology
Research Overview
- Evaluation of Mosunetuzumab and Polatuzumab Vedotin Combination in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Patients
- Phase 3 Randomized Trial of Talquetamab, Daratumumab, and Pomalidomide Combinations in Relapsed/Refractory Multiple Myeloma Post-One Therapy Line
- Phase 3 Randomized Study of Zanubrutinib vs. Bendamustine and Rituximab in Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Data & Insights
Has run more than one trial at 112 of 296 partner sites.
Specializations
Hematologic Malignancies
The investigator specializes in treating chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL), with particular focus on novel therapeutic approaches for both treatment-naive and previously treated patients.
- Targeted therapy combinations
- BTK inhibitor therapy
- BCL-2 inhibitor applications
Key interest in developing treatment strategies for patients who have received prior therapies, including optimization of combination approaches.
Multiple Myeloma Management
Extensive involvement in advancing treatments for multiple myeloma, particularly focusing on both newly diagnosed transplant-ineligible patients and those with relapsed/refractory disease.
- Novel antibody-based therapies
- Immunomodulatory combinations
- Anti-CD38 directed treatments
Active engagement in developing innovative therapeutic combinations incorporating monoclonal antibodies and targeted agents.
Treatment Resistance
Specialized focus on addressing treatment-resistant hematologic cancers, particularly in developing strategies for patients who have progressed on standard therapies.
- Alternative treatment pathways
- Novel drug combinations
- Sequential therapy approaches
Dedicated to exploring innovative treatment options for patients who have exhausted conventional therapeutic options.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.